Study | n | Duration (months) | Treatment 1 | EF change* | Treatment 2 | EF change* | Absolute difference |
---|---|---|---|---|---|---|---|
*Absolute percentage change in ejection fraction. | |||||||
Present study | 34 | 6 | Carvedilol | 8 | Placebo | −2 | 10 |
Metra44 | 34 | 4 | Carvedilol | 10 | Placebo | −1 | 11 |
Olsen1 | 57 | 4 | Carvedilol | 11 | Placebo | 1 | 10 |
Krum23 | 43 | 4 | Carvedilol | 7 | Placebo | 0 | 7 |
MOCHA study24 | 143 | 7 | Carvedilol | 9 | Placebo | 1 | 8 |
PRECISE study25 | 225 | 7 | Carvedilol | 8 | Placebo | 2 | 6 |
Colucci26 | 185 | 7 | Carvedilol | 10 | Placebo | 3 | 7 |
Cohn27 | 55 | 7 | Carvedilol | 9 | Placebo | 2 | 7 |
ANZ study3 | 358 | 12 | Carvedilol | 5 | Placebo | 0 | 5 |
Guazzi28 | 21 | 6 | Carvedilol | 9 | Placebo | −1 | 10 |
DiLenarda29 | 30 | 12 | Carvedilol | 7 | Metoprolol | 0 | 7 |
Metra22 | 122 | 14 | Carvedilol | 11 | Metoprolol | 7 | 4 |
Kukin6 | 53 | 6 | Carvedilol | 6 | Metoprolol | 5 | 1 |
Sanderson30 | 43 | 3 | Carvedilol | 9 | Metoprolol | 6 | 3 |
Engelmeier31 | 24 | 12 | Metoprolol | 6 | Placebo | 4 | 2 |
MDC study32 | 205 | 12 | Metoprolol | 12 | Placebo | 6 | 6 |
Fisher33 | 50 | 6 | Metoprolol | 4 | Placebo | 0 | 4 |
Goldstein34 | 51 | 6 | Metoprolol | 9 | Placebo | 2 | 7 |
RESOLVD study35 | 419 | 6 | Metoprolol | 3 | Placebo | 1 | 2 |